Cedars-Sinai International

Don't miss this Spotlight interview in the Medical Tourism Magazine with Dr. Heitham Hassoun, Chief Executive of Cedars-Sinai International, to discuss Cedars-Sinai's remarkable journey in global healthcare. Dr. Hassoun shares his insights and wealth of experience in overcoming challenges, the importance of culture in healthcare, and his vision for the future impact of Cedars-Sinai on global healthcare. #leadership #excellenceinhealthcare #globalhealthcare #inspiration #internationalleaders

Great 5 days with Cedar Sinai International at Taikang Hospital, Shenzhen. Evidence Based Practice Quality and Patient Safety Clinical training and readiness Nursing focused training #Nursing #Hospitals All the Best with the opening next month! Cedars-Sinai International Yiming Yuan Nicole Rosson Heitham Hassoun

Proud to be recognized 9 years in a row on the “Best Hospitals” Honor Roll by U.S. News & World Report. We continue to strive to bring the Cedars-Sinai 'Excellence in Healthcare' closer to all our patients wherever they are.

We’re proud to be recognized 9 years in a row on the “Best Hospitals” Honor Roll by U.S. News & World Report.

Looking forward to a fruitful collaboration with the team at the University of Surrey!

Following an extensive national search, we are delighted to share that Cedars-Sinai has named Peter L. Slavin, MD, as the next president and CEO of Cedars-Sinai Medical Center and president and CEO of Cedars-Sinai Health System, effective Oct. 1. Dr. Slavin, one of the nation’s premier leaders in academic medicine, succeeds Thomas M. Priselac, who is retiring after 30 years as president and CEO and 45 total years of total service to Cedars-Sinai. Dr. Slavin served as president of Massachusetts General Hospital, one of the largest hospitals in the U.S., from 2003 to 2021. During his tenure, he successfully led major growth in the hospital’s clinical care mission, research funding, scientific impact, workforce development and fundraising. We thank Tom Priselac for his extraordinary contributions to Cedars-Sinai and warmly welcome Dr. Slavin to the Cedars-Sinai family. We look forward to him strengthening Cedars-Sinai’s mission to serve as a beacon of healing and hope to our patients and our community. More info at https://ceda.rs/4eJYvAH.

Cedars-Sinai's recent studies on ventricular tachycardia are leading to new understandings and treatments. Eugenio Cingolani, MD, and his team are developing cell-derived therapies aimed at managing heart rhythms more effectively, with the potential to enhance treatment modalities while minimizing side effects. Supported by a $6 million grant, this research is moving towards clinical trials, reflecting our commitment to improving heart health with scientifically robust methods. Link in bio to learn more.

Researchers at Cedars-Sinai, alongside global collaborators, have identified critical genetic regions influencing ovarian cancer risk. This extensive analysis, leveraging data from over 126,000 women, pinpoints five new genetic areas, opening doors to more targeted interventions. Read more. ⬇️

Cedars-Sinai team is proud to have earned the Global Healthcare Accreditation for the second time for providing international patients with highest quality healthcare and services. "Cedars-Sinai's unique combination of leading-edge research, world-class medical education, and exceptional patient care has established us as a global healthcare leader. Our multidisciplinary approach allows us to provide comprehensive, tailored care to patients from our local community and those who travel from around the world,” said Heitham Hassoun, MD, chief executive of Cedars-Sinai International. Learn more here https://ceda.rs/4cILshb

Cedars-Sinai team was pleased to welcome Ms. Maria Aponte, International Director, Mr. Theodore Constantinau, CEO, and Dr. Jorge Verbel, CMO, from Panama Clinic at our campus in Los Angeles, California. Luis Felipe Arango Pardo MHA Benjamin H. Seo Arshia Yadav, MPH